BLU2864

• CAT Number: I042872
• CAS Number: 2810747-89-6
• Molecular Formula: C24H19F3N4O2
• Molecular Weight: 452.43
• Purity: ≥95%
• Synonyms: N-[(1R,2S)-5-(difluoromethyl)-7-fluoro-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-6-(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)pyridine-3-carboxamide
• InChI: InChI=1S/C24H19F3N4O2/c1-11-9-30-23-19(11)15(4-5-28-23)17-3-2-12(10-29-17)24(33)31-21-18(32)8-13-6-14(22(26)27)7-16(25)20(13)21/h2-7,9-10,18,21-22,32H,8H2,1H3,(H,28,30)(H,31,33)/t18-,21-/m0/s1
• InChIKey: VRPOVDLLZCQZEG-RXVVDRJESA-N
• SMILES: CC1=CNC2=NC=CC(=C12)C3=NC=C(C=C3)C(=O)N[C@H]4[C@H](CC5=C4C(=CC(=C5)C(F)F)F)O

BLU2864（Cat No.:I042872）is an experimental small molecule being investigated for its potential use in treating various types of cancer, particularly those with specific genetic mutations. It functions as an inhibitor of certain protein kinases involved in cancer cell growth, survival, and metastasis. By targeting these molecular pathways, BLU2864 aims to disrupt tumor progression and overcome resistance to existing therapies. Early preclinical studies have shown promising results in inhibiting tumor growth and enhancing treatment efficacy. Ongoing research is focused on evaluating its safety, pharmacokinetics, and potential therapeutic benefits in clinical trials.